腫瘍微小環境-cold打破
●Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment 【雑誌】J Immunother Cancer. 2022 Jul;10(7):e004695 (pubmed )https://pubmed.ncbi.nlm.nih.gov/3586…
Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy（Docetaxelは前立腺癌の腫瘍免疫微小環境を再構築し免疫チェックポイント阻害薬の効果を増強する） 【Theranostics. 2022 Jun 27;12(11…
